Literature DB >> 24689946

Belimumab may not prevent lupus nephritis in serologically active patients with ongoing non-renal disease activity.

C Sjöwall1, L Cöster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24689946     DOI： 10.3109/03009742.2014.887769

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  8 in total

Review 1.  B Cell-Based Treatments in SLE: Past Experience and Current Directions.

Authors:  Stamatis-Nick C Liossis; Chrysanthi Staveri
Journal:  Curr Rheumatol Rep       Date:  2017-11-04       Impact factor: 4.592

Review 2.  Lupus Nephritis: Improving Treatment Options.

Authors:  Myrto Kostopoulou; Sofia Pitsigavdaki; George Bertsias
Journal:  Drugs       Date:  2022-04-29       Impact factor: 9.546

3.  Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review.

Authors:  Elisabetta Chessa; Matteo Piga; Alberto Floris; Mattia Congia; Ignazio Cangemi; Alessandro Mathieu; Alberto Cauli
Journal:  BioDrugs       Date:  2021-02-17       Impact factor: 5.807

Review 4.  Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review.

Authors:  Domenico Paolo Emanuele Margiotta; Fabio Basta; Veronica Batani; Antonella Afeltra
Journal:  BMC Nephrol       Date:  2018-03-07       Impact factor: 2.388

Review 5.  Management of Lupus Nephritis.

Authors:  Farah Tamirou; Frédéric A Houssiau
Journal:  J Clin Med       Date:  2021-02-09       Impact factor: 4.241

Review 6.  Belimumab for systemic lupus erythematosus - Focus on lupus nephritis.

Authors:  Marlene Plüß; Silvia Piantoni; Björn Tampe; Alfred H J Kim; Peter Korsten
Journal:  Hum Vaccin Immunother       Date:  2022-05-19       Impact factor: 4.526

7.  Clinical Efficacy of Routinely Administered Belimumab on Proteinuria and Neuropsychiatric Lupus.

Authors:  Marlene Plüß; Björn Tampe; Noah Niebusch; Michael Zeisberg; Gerhard A Müller; Peter Korsten
Journal:  Front Med (Lausanne)       Date:  2020-05-27

8.  Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report.

Authors:  Francesco Fontana; Gaetano Alfano; Marco Leonelli; Caterina Cerami; Giulia Ligabue; Amelia Spinella; Giorgia Citriniti; Carlo Umberto Manzini; Clodoveo Ferri; Gianni Cappelli
Journal:  BMC Nephrol       Date:  2018-10-20       Impact factor: 2.388
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.